Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Have a think!!

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Apr 17, 2024 7:54am

109 Views

Post# 35993244

RE:RE:RE:RE:RE:RE:RE:Have a think!!

Nice to hear from you norm I never denied have different names on other boards because that is how I signed up when I heard about them.
As for a conversation with myself, well that is a funny one but not true plain and simple.
As for lying, kinda hard do do when the corrections you do are a cut and paste from a pr or cc otherwise I try and state imo.
Yes I am frustrated and admit it but spreading falsehoods I do not do and if I make a mistake at least I will admit it.
I still think we have great potential but as for who is running the ship well that is another question.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale